Literature DB >> 6918183

Modulation of the formation of the human C-3 amplification convertase of complement by polyelectrolytes.

M D Kazatchkine, F Maillet, E Fischer, D Glotz.   

Abstract

Heparin in the fluid phase inhibits generation of the C3 amplification convertase of complement C3b,Bb. The anticomplementary activity requires the presence of O-sulfate groups on the molecule and is suppressed when the negative charges of heparin are neutralized with positive charges on polycations. In the absence of heparin, polycations inhibit generation of the cell-bound or fluid phase amplification convertase at final concentrations of 1 to 2 x 10(-8) M for poly-L- lysine 50,000 (PLL). PLL is more active on the D-dependent convertase C3b,Bb than in preventing generation of C3b,B; it does not alter the stabilizing effect of properdin. As for heparin, the major site of the inhibitory action of polycations is on the binding capacity of C3b for B. The low affinity interaction of C3b and B is a privileged site for potential pharmacologic modulation of the amplification convertase of complement by polyelectrolytes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6918183     DOI: 10.1007/bf01978777

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  5 in total

1.  The modulation of the alternative pathway of complement in C2-deficient human serum by changes in concentration of the component and control proteins.

Authors:  U E Nydegger; D T Fearon; K F Austen
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

2.  Complement activation by interaction of polyanions and polycations. I. Heparin-protamine induced consumption of complement.

Authors:  R Rent; N Ertel; R Eisenstein; H Gewurz
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

3.  Studies of the inhibition of C56-initiated lysis (reactive lysis). IV. Antagonism of the inhibitory activity c567-INH by poly-L-lysine.

Authors:  B McLeod; P Baker; C Behrends; H Gewurz
Journal:  Immunology       Date:  1975-02       Impact factor: 7.397

4.  Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertase.

Authors:  M D Kazatchkine; D T Fearon; D D Metcalfe; R D Rosenberg; K F Austen
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

5.  Modulation of the formation of the amplification convertase of complement, C3b, Bb, by native and commercial heparin.

Authors:  J M Weiler; R W Yurt; D T Fearon; K F Austen
Journal:  J Exp Med       Date:  1978-02-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.